Alkermes ALKS
NASDAQ ALKS
$45.31 -0.18 (-0.40%)
As of: Sep 9, 2026 · 2:08 PM EDT

Alkermes (ALKS) Operating Income (2010 - 2026)

Alkermes' (ALKS) quarterly Operating Income came in at $18.4 million in Q2 2026, down 80.26% year-over-year from $93.0 million in Q2 2025, and up 138.01% quarter-over-quarter from -$48.3 million in Q1 2026.

Analysis

Alkermes (ALKS) Operating Income (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Operating Income for 17 consecutive years, with $18.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Income fell 80.26% year-over-year to $18.4 million in Q2 2026; TTM through Jun 2026 was $117.3 million, a 68.67% decrease from a year earlier, with the FY2025 full-year figure at $254.0 million, down 39.63% from the prior year.
  • Operating Income was $18.4 million for Q2 2026 at Alkermes, up from -$48.3 million in the prior quarter.
  • Over five years, Operating Income peaked at $281.3 million in Q2 2023 and troughed at -$60.6 million in Q3 2022.
  • A 5-year average of $58.5 million and a median of $56.4 million in 2023 frame the typical range for Operating Income.
  • Across the five-year window, Operating Income slumped 879.39% in 2022 and surged 916.29% in 2023, its largest moves.
  • Over 5 years, Operating Income stood at $115.6 million in 2022, then slumped by 52.74% to $54.6 million in 2023, then surged by 197.79% to $162.7 million in 2024, then slumped by 64.29% to $58.1 million in 2025, then slumped by 68.41% to $18.4 million in 2026.
  • The last three Operating Income figures came in at $18.4 million (Q2 2026), -$48.3 million (Q1 2026), and $58.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 646.92 Bn 626.16 Bn 17.26 Bn 7.14 Bn
2 AbbVie 441.93 Bn 435.36 Bn 12.70 Bn 6.43 Bn
3 Merck 365.88 Bn 358.74 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn 4.75 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn 4.27 Bn
6 Sanofi 52.44 Bn 45.05 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 44.05 Bn 44.05 Bn - -505.13 Mn
8 Incyte 25.31 Bn 20.78 Bn 1.57 Bn 697.90 Mn
9 United Therapeutics 21.45 Bn 18.78 Bn 683.80 Mn 330.80 Mn
10 Alkermes 7.57 Bn 6.91 Bn 397.90 Mn 18.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.35 Mn
Mar 31, 2026 -48.28 Mn
Dec 31, 2025 58.10 Mn
Sep 30, 2025 89.08 Mn
Jun 30, 2025 92.98 Mn
Mar 31, 2025 13.79 Mn
Dec 31, 2024 162.69 Mn
Sep 30, 2024 104.76 Mn
Jun 30, 2024 109.88 Mn
Mar 31, 2024 43.31 Mn
Dec 31, 2023 54.63 Mn
Sep 30, 2023 89.19 Mn
Jun 30, 2023 281.27 Mn
Mar 31, 2023 -10.97 Mn
Dec 31, 2022 115.59 Mn
Sep 30, 2022 -60.64 Mn
Jun 30, 2022 -34.46 Mn
Mar 31, 2022 -26.59 Mn
Dec 31, 2021 129.42 Mn
Sep 30, 2021 -19.66 Mn